(NASDAQ:TLSA), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis […]

(NASDAQ:CDMO),(NASDAQ:CDMOP), TUSTIN, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has mailed a letter to stockholders

(NASDAQ:ADPT), SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2024 after market close

(NASDAQ:AVPT), JERSEY CITY, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the global leader in data security, governance, and resilience, will report its fourth quarter and full year 2024 financial results after the US financial markets close on Thursday, February 27, 2025. The Company will also host an Investor Day at 8:30am ET

(NASDAQ:CBUS), SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating

(NASDAQ:VECO), PLAINVIEW, N.Y., Jan. 22, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its fourth quarter 2024 financial results after the market closes on Wednesday, February 12, 2025. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial

(NYSE:PSN), CHANTILLY, Va., Jan. 22, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Command, Control, Communications, Computer, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) Center in support of Project Linchpin, the Army's emerging Artificial Intelligence and Machine

(NASDAQ:ACVA), BUFFALO, N.Y., Jan. 22, 2025 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, announced today that the Company will report fourth quarter 2024 financial results after market close and host a conference call at 5:00 p.m. ET on Wednesday, February 19, 2025.

(NASDAQ:LFVN), SALT LAKE CITY, Jan. 22, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2024, after the stock market closes on Wednesday, February

(NASDAQ:NOTV), WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2025 first